During the three and six months ended December 31, 2025, the Company recorded impairment and restructuring charges of $30 million and $49 million, including restructuring charges of $22 million and $36 million, respectively.

During the three and six months ended December 31, 2024, the Company recorded restructuring charges of $16 million and $38 million, respectively, and there were no impairment charges.


	For the three months ended December 31,
	2025				2024
	One time employee termination benefits		Other costs		Total		One time employee termination benefits		Other costs		Total
	(in millions)
Balance, beginning of period	$	37	$	46	$	83	$	24	$	33	$	57
Additions	21		1		22		15		1		16
Payments	(37)		(2)		(39)		(20)		(2)		(22)
Other	—		—		—		(1)		(1)		(2)
Balance, end of period	$	21	$	45	$	66	$	18	$	31	$	49


	For the six months ended December 31,
	2025				2024
	One time employee termination benefits		Other costs		Total		One time employee termination benefits		Other costs		Total
	(in millions)
Balance, beginning of period	$	42	$	46	$	88	$	25	$	34	$	59
Additions	35		1		36		36		2		38
Payments	(60)		(3)		(63)		(42)		(4)		(46)
Other	4		1		5		(1)		(1)		(2)
Balance, end of period	$	21	$	45	$	66	$	18	$	31	$	49

As of December 31, 2025, restructuring liabilities of $25 million were included in the Balance Sheet in Other current liabilities and $41 million were included in Other non-current liabilities.